Navigation Links
Osteologix Announces Dividend
Date:12/20/2011

BRAY, Ireland, December 20, 2011 /PRNewswire/ --

Osteologix Holdings, PLC ("Osteologix" or the "Company") declared a dividend of Euro 0.06 per sharepayable to shareholders of record on December 19, 2011.  The payment date will be February 15, 2012.  The payment date is being delayed to allow time for certain Irish Dividend WithholdingTax ("DWT") exemption forms to be returned to the Company by shareholders prior to dividend payment.

Shareholders who are not Irish residents may be entitled to an exemption from DWT. Those shareholders should complete a DWT exemption form, available on the Company's website, and return it to the Company.  Shareholders who are entitled to an exemption but who do not return the relevant forms prior to the payment date will have DWT deducted from their dividend, however, they may subsequently apply to the Irish Revenue authorities for a refund of DWT.

In July, 2010 Osteologix granted the Servier Research Group an exclusive royalty bearing license to develop and commercialize strontium salt products covered by Osteologix's patent rights to treat post-menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S.Assuming  continued milestone payments, and the anticipated royalties from the Company's license agreement with the Servier Research Group, Osteologix looks forward to the potential to continue operating on a positive cash flow basis with the possibility for annual dividend payments.

About Osteoporosis

The World Health Organization defines osteoporosis as a progressive skeletal disease characterized by low bone mass and micro-architectural deterioration of bone tissue with a consequential increase in bone fragility and susceptibility to fracture. There is increased risk of fracture particularly of spine, hip, pelvis and forearm. It is predominantly a disease of post-menopausal women and risk of fracture increases with age.
'/>"/>

SOURCE Osteologix Holdings PLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Osteologix Announces Completion of Corporate Consolidation
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
4. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
5. Anesiva Announces Second Quarter 2008 Financial Results and Update
6. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
7. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
8. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. ThirdBiotech Announces Kemeta as Newest Sponsor
11. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Pipette.com has added the ... their comprehensive portfolio of Eppendorf products. , The Eppendorf ... a Centrifuge 5424/5424 R and receive the following:, ... Research plus or Eppendorf Reference 2 , ...
(Date:1/22/2015)... Selexis SA, a serial innovation company ... (RCBs) used for drug discovery to commercial manufacturing, announced ... Next-Generation Sequencing (NGS) data packages. The NGS ... by ensuring the integrity of the gene, validation of ...
(Date:1/22/2015)... Jan. 22. 2015  Varian Medical Systems (NYSE: VAR ... honored for its commitment to sustainability with inclusion on a ... the highest ranked healthcare equipment company among the Corporate Knights ... World Economic Forum at Davos, Switzerland . ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... TEL AVIV, Israel, Jan. 31, 2012   InspireMD, Inc. ... medical device company focusing on the development and ... use in patients with Acute Myocardial Infarctions, today ... its Board of Directors as an independent director.  ...
... world, with the potential to create foldaway mobile phones, wallpaper-thin ... finding at the University of Manchester gives graphene,s potential a ... distilling alcohol. In a report published in Science ... that graphene-based membranes are impermeable to all gases and liquids ...
... technique builds on previous research in which microbubbles were used ... an oil which can be processed to create a useful ... alternative to fossil fuels and algae, in particular, has the ... however, there has been no cost-effective method of harvesting and ...
Cached Biology Technology:InspireMD Appoints Dr. James Barry to Its Board of Directors 2InspireMD Appoints Dr. James Barry to Its Board of Directors 3InspireMD Appoints Dr. James Barry to Its Board of Directors 4Supermaterial goes superpermeable 2Microbubbles provide new boost for biofuel production 2
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... the "Samsung Galaxy S5 - Home Button Synaptics ... http://photos.prnewswire.com/prnh/20130307/600769 ... iPhone 5S, Samsung introduces for the first time a ...
(Date:12/17/2014)... Dec. 16, 2014  Automation is fundamentally transforming the travel ... international borders. Over the past decade, ePassports, biometric readers, ... self process through border control via eGates and Automated ... airports, seaports, and land borders across the globe. ...
(Date:12/11/2014)... Dec. 10, 2014  Data Sciences International (DSI), the ... a new series of digital telemetry implants to ... M series, part of the PhysioTel™ Digital platform, ... possible physiologic data when incorporating functional endpoints into ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... explosion in the number of people over the age of 50 ... of the population will be over the age of 50 and ... a warning call for health authorities and medical professionals who must ... diseases such as osteoporosis. In response to the need ...
... Texas, May 10, 2012 /PRNewswire-iReach/ -- WanderID ... in Western Travis County. Used to identify individuals who ... Alzheimer,s patients and young and/or special needs children, the ... responders, including the Lakeway Police Department [credit: KXAN video ...
... 9, 2012 While we often think of memory as ... are, little thought is given to the importance of forgetting ... "horrible memories department" or just reflects the minutia of day-to-day ... exactly how we forgetthe molecular, cellular, and brain circuit mechanisms ...
Cached Biology News:WanderID Launches Breakthrough ID Product for Children, Seniors 2Scripps Florida scientists identify neurotranmitters that lead to forgetting 2Scripps Florida scientists identify neurotranmitters that lead to forgetting 3
...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
Goat anti-VAV2 Class: Antibody Product Group: Miscellaneous Antibody...
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications)....
Biology Products: